| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 712570 | 1151024002 | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 100 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002/1151024002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002/1151024002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | MERCK SHARP & DOHME DE ESPANA S.A. | 2016-09-23 | 1 | 1 | 1 | 2016-09-24 | 2016-09-23 | 1 | 2017-05-30 | View Edit Delete | ||||||||||||
| 727090 | 1151024002IP | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 100 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002IP/1151024002IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002IP/1151024002IP_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | ABACUS MEDICINE A/S | 2019-10-17 | 1 | 1 | 1 | 2019-10-18 | 2019-10-17 | 1 | 2020-03-19 | View Edit Delete | ||||||||||||
| 730386 | 1151024002IP1 | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | KEYTRUDA 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 4 ml | 100 mg inyectable 4 ml | 45 | 1 | 34 | 1 vial de 4 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151024002IP1/1151024002IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151024002IP1/1151024002IP1_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34945 | MELYFARMA S.L. | 2021-02-15 | 1 | 1 | 1 | 2021-02-16 | 2021-02-15 | 1 | 2021-09-14 | View Edit Delete | ||||||||||||
| 711286 | 1161101001 | DARZALEX 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | DARZALEX 20 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial de 5 ml | 100 mg inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1161101001/1161101001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1161101001/1161101001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 6153 | JANSSEN CILAG S.A. | 2016-06-23 | 1 | 1 | 1 | 2016-06-24 | 2016-06-23 | 1 | 2016-11-08 | View Edit Delete | ||||||||||||
| 731078 | 85988 | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS, 28 cápsulas | 100 mg/1 mg | 5 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85988/85988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85988/85988_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | THERAMEX HEALTHCARE SPAIN S.L. | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2021-09-26 | View Edit Delete | ||||||||||||
| 731079 | 85988 | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS | BIJUVA 1 MG/100 MG CAPSULAS BLANDAS, 84 cápsulas | 100 mg/1 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/85988/85988_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/85988/85988_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29320 | THERAMEX HEALTHCARE SPAIN S.L. | 2021-05-28 | 1 | 1 | 1 | 2021-05-29 | 2021-05-28 | 1 | 2021-09-26 | View Edit Delete | ||||||||||||
| 733266 | 86708 | METSUNIX 100 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA | METSUNIX 100 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA, 28 comprimidos | 100 mg/1.000 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86708/86708_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86708/86708_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2022-03-31 | 1 | 2023-07-01 | View Edit Delete | ||||||||||||
| 733267 | 86708 | METSUNIX 100 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA | METSUNIX 100 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA, 56 comprimidos | 100 mg/1.000 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86708/86708_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86708/86708_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16612 | ADAMED LABORATORIOS S.L.U. | 2022-03-31 | 1 | 1 | 1 | 2022-04-01 | 2022-03-31 | 1 | 2023-07-01 | View Edit Delete | ||||||||||||
| 734867 | 86867 | ESTEQUEN 100 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA | ESTEQUEN 100 MG/1.000 MG COMPRIMIDOS DE LIBERACION MODIFICADA, 28 comprimidos | 100 mg/1.000 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86867/86867_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86867/86867_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2022-04-19 | 1 | 1 | 1 | 2022-04-20 | 2022-04-19 | 1 | 2023-06-14 | View Edit Delete | ||||||||||||
| 672887 | 73106 | LOSARTAN/HIDROCLOROTIAZIDA TECNIGEN 100 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LOSARTAN/HIDROCLOROTIAZIDA TECNIGEN 100 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 100 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73106/73106_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73106/73106_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12947 | TECNIMEDE ESPAÑA INDUSTRIA FARMACEUTICA S.A. | 2010-11-30 | 1 | 1 | 1 | 2010-11-30 | 2010-11-30 | 1 | 2011-06-15 | View Edit Delete | ||||||||||||
| 676112 | 72937 | LOSARTAN/HIDROCLOROTIAZIDA KRKA 100 MG/12.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LOSARTAN/HIDROCLOROTIAZIDA KRKA 100 MG/12.5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 100 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72937/72937_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72937/72937_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2015-10-16 | 1 | 1 | 1 | 2015-10-16 | 2016-03-09 | 1 | 2016-06-21 | View Edit Delete | ||||||||||||
| 679476 | 73846 | LAVESTRA HCT 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LAVESTRA HCT 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 100 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73846/73846_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73846/73846_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2013-03-07 | 1 | 1 | 1 | 2013-03-07 | 2013-03-20 | 1 | 2013-08-19 | View Edit Delete | ||||||||||||
| 683049 | 74569 | LOSARTAN/HIDROCLOROTIAZIDA TEVA-RATIO 100/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | LOSARTAN/HIDROCLOROTIAZIDA TEVA-RATIO 100/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos (Al/PVC/PE/PVDC) | 100 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos (Al/PVC/PE/PVDC) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74569/74569_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74569/74569_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2011-12-09 | 1 | 1 | 1 | 2011-12-09 | 2011-12-09 | 1 | 2012-04-03 | View Edit Delete | ||||||||||||
| 700060 | 78072 | LOSARTAN/HIDROCLOROTIAZIDA AUROVITAS 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | LOSARTAN/HIDROCLOROTIAZIDA AUROVITAS 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 100 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78072/78072_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78072/78072_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2015-01-19 | 1 | 1 | 1 | 2015-01-19 | 2015-01-27 | 1 | 2018-07-18 | View Edit Delete | ||||||||||||
| 764009 | 89223 | LOSARTÁN/HIDROCLOROTIAZIDA CINFA 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | LOSARTÁN/HIDROCLOROTIAZIDA CINFA 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG, 28 comprimidos | 100 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89223/89223_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89223/89223_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2024-01-09 | 1 | 1 | 1 | 2024-01-10 | 2024-01-09 | 1 | 2024-06-12 | View Edit Delete | ||||||||||||
| 768091 | 90444 | LOSARTAN/HIDROCLOROTIAZIDA NORMON 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN/HIDROCLOROTIAZIDA NORMON 100 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 100 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90444/90444_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90444/90444_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2025-07-11 | 1 | 1 | 1 | 2025-07-12 | 2025-07-11 | 1 | 2025-09-12 | View Edit Delete | ||||||||||||
| 721175 | 1151059005 | ORKAMBI 100 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ORKAMBI 100 MG/125 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 112 (4 x 28) comprimidos | 100 mg/125 mg | 5 | 112 | 10 | 112 (4 x 28) comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151059005/1151059005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151059005/1151059005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 49010 | VERTEX PHARMACEUTICALS (SPAIN) S.L. | 2018-04-05 | 1 | 1 | 1 | 2018-04-06 | 2018-04-05 | 1 | 2019-10-15 | View Edit Delete | ||||||||||||
| 725019 | 1151059006 | ORKAMBI 100 MG/125 MG GRANULADO EN SOBRE | ORKAMBI 100 MG/125 MG GRANULADO EN SOBRE, 56 sobres | 100 mg/125 mg | 35 | 56 | 64 | 56 sobres | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1151059006/1151059006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1151059006/1151059006_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 49010 | VERTEX PHARMACEUTICALS (SPAIN) S.L. | 2019-02-28 | 1 | 1 | 1 | 2019-03-01 | 2019-02-28 | 1 | 2022-06-14 | View Edit Delete | ||||||||||||
| 724212 | 1181306001 | SYMKEVI 100 MG/150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | Symkevi 100mg/150mg comprimidos recubiertos con pelicula, 28 comprimidos | 100 mg/150 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1181306001/1181306001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1181306001/1181306001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 49010 | VERTEX PHARMACEUTICALS (SPAIN) S.L. | 2019-01-17 | 1 | 1 | 1 | 2019-01-18 | 2019-01-17 | 1 | 2019-10-15 | View Edit Delete | ||||||||||||
| 650440 | 49131 | BESTER COMPLEX CÁPSULAS DURAS | BESTER COMPLEX CÁPSULAS DURAS, 30 cápsulas | 100 mg/150 mg/1,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49131/49131_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49131/49131_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 1970-11-01 | 1 | 1 | 1 | 1970-11-01 | 1995-02-01 | 1 | 2011-07-04 | View Edit Delete |
Page 232 of 1036, showing 20 records out of 20709 total, starting on record 4621, ending on 4640